Effects of Ginkgo Biloba on memory and cognitive function in patients with Alzheimer's disease
Authors:
- Pedro César de SouzaPSPedro César de Souza
- Thaynara Paula Warren BezerraTBThaynara Paula Warren Bezerra
- Isabella Luiza Ralph de OliveiraIOIsabella Luiza Ralph de Oliveira
- Maria Isabela Ferreira de AraujoMAMaria Isabela Ferreira de Araujo
- Yasmin Carvalho da Rocha WanderleyYWYasmin Carvalho da Rocha Wanderley
- Djair Marques Dias JúniorDJDjair Marques Dias Júnior
- Anaías Carine da SilvaASAnaías Carine da Silva
- Niedja Paula Vieira de MoraesNMNiedja Paula Vieira de Moraes
- Paulo André Teixeira de Morais GomesPGPaulo André Teixeira de Morais Gomes
- Eduardo Augusto Vasconcelos de Freitas RamalhoEREduardo Augusto Vasconcelos de Freitas Ramalho
- Michelle Melgarejo da RosaMRMichelle Melgarejo da Rosa
- Marina Galdino da Rocha PittaMPMarina Galdino da Rocha Pitta
Open Access
- 1 August 2024
- journal article
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 21 (8) , e6968
Abstract
This integrative review aims to synthesize scientific evidence on the effects of Ginkgo biloba on memory and cognitive function in patients with Alzheimer’s disease. Twenty-five studies published between 2010 and 2023 were analyzed, including randomized clinical trials, observational studies, and systematic reviews. The databases used included PubMed, Scopus, ScienceDirect, and SciELO, with keywords such as "Ginkgo biloba," "Alzheimer's disease," "cognitive function," and "neuroprotection." The results indicate that Ginkgo biloba possesses neuroprotective, antioxidant, and anti-inflammatory properties that contribute to the improvement of cognitive function in patients with Alzheimer's disease. Several studies demonstrated that Ginkgo biloba supplementation results in significant improvements in memory, attention, and executive function. Additionally, the combination of Ginkgo biloba with conventional treatments, such as cholinesterase inhibitors, proved to be particularly effective, enhancing therapeutic effects and offering a more holistic approach to disease management. Despite the promising results, the review highlights the need for more well-controlled, long-term clinical trials to standardize dosages and treatment protocols, as well as to confirm the safety and efficacy of Ginkgo biloba. The variability in study methods and administered dosages was a significant limitation, pointing to the need for further research in this area. In conclusion, Ginkgo biloba emerges as a valuable and promising therapeutic alternative in the management of Alzheimer's disease, offering improvements in cognitive function and quality of life for patients.Keywords
This publication has 17 references indexed in Scilit:
- A bibliometric and thematic analysis of the trends in the research on ginkgo biloba extract from 1985 to 2022Heliyon, 2023
- Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer’s diseaseInflammopharmacology, 2023
- Protective and therapeutic role of Ginkgo biloba extract through TRPV1 channels in an in vitro Alzheimer's disease model.Archives of Neuropsychiatry, 2023
- Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory StudyAlzheimer's & Dementia, 2022
- Association Between Ginkgo Biloba Extract Prescriptions and Dementia Incidence in Outpatients with Mild Cognitive Impairment in Germany: A Retrospective Cohort StudyJournal of Alzheimer’s Disease, 2022
- The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s DiseaseFrontiers in Pharmacology, 2021
- Ginkgo Biloba Extract Is Comparable With Donepezil in Improving Functional Recovery in Alzheimer’s Disease: Results From a Multilevel Characterized Study Based on Clinical Features and Resting-State Functional Magnetic Resonance ImagingFrontiers in Pharmacology, 2021
- Neuroregulatory role of ginkgolidesMolecular Biology Reports, 2021
- Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathwayPLOS ONE, 2019
- Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological DisordersNeurotherapeutics, 2019